Completed OBSERVATIONAL NCT01527396

Prospective, Observational Study of Low-risk Criteria for Node Metastasis in Endometrial Cancer (PALME)

Multi-center Prospective Observational Study for the Validation of Preoperative Low-risk Criteria for Lymph Node Metastasis in Endometrial Cancer

Sponsor: Korean Gynecologic Oncology Group

Conditions Endometrial Cancer

Updated 7 times since 2017 Last updated: Oct 27, 2015 Started: Dec 31, 2011 Primary completion: Dec 31, 2014 Completion: Aug 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Endometrial Cancer and is currently completed. Korean Gynecologic Oncology Group leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Dec 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Korean Gynecologic Oncology Group
National Cancer Center, Korea

Data source: National Cancer Center, Korea

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea